Noema Pharma
PrivateLast Round
Series B
Extension
Dec 11, 2024
Total Funding Raised
$241M
Company Overview
Noema Pharma is a biotechnology company that develops innovative therapeutic solutions for central nervous system conditions, particularly targeting severe neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Noema Pharma Comparables
Compare Noema Pharma with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Eumentis Therapeutics Inc. | 83% | |
| Addex Therapeutics | 82% | |
| Neurosterix | 79% | |
Noema Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Dec 11, 2024 | ||||
| Series B | Mar 7, 2023 | ||||
| Series A | Dec 1, 2020 |
Key People
Founding team and executive leadership
Noema Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| BioMedPartners | Series B, Series A |
| EQT Life Sciences | Series B Extension, Series B |
| Forbion | Series B |
| Gilde Healthcare | Series B, Series A, Series B Extension |
| Invus Opportunities | Series B, Series A, Series B Extension |
| Sofinnova Partners | Series B, Series B Extension, Seed, Series A |
| UPMC Enterprises | Series B, Series B Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
Michael Samar appointed as the new Chief Financial Officer.
- Mar 7, 2023
$147M round led by Jeito, EQT Life Sciences, and Forbion.
Noema Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Noema Pharma's valuation, stock price, and market status.